Welcome

!! GlycoExpress receives regulatory approval !!

Welcome to Glycotope the worldwide leading biopharmaceutical company in glycomics and its application for development of biopharmaceuticals.

Learn about our unique expertise in glycooptimization of biopharmaceuticals and how we can support you in providing better therapeutic healthcare products.

For information about our GMP manufacturing capabilities and a wide variety of CE certified immunodiagnostic kits please visit Glycotope Biotechnology

Print

PLATFORM TECHNOLOGIES

Glycooptimization of biotherapeutics (based on a toolbox of human glycoengineered cell lines) & recombinant antibody technologies

BIOPHARMACEUTICAL PRODUCTS

Proprietary and largely improved 2^nd generation antibodies & other biotherapeutics

ONE-STOP-SERVICE

Development of biotherapeutics from the gene via glycooptimization to the drug produced under cGMP including fill & finish

At our affiliate GLYCOTOPE BIOTECHNOLOGY

Immunodiagnostic Kits

European Life Science CEO Forum

Zurich, Switzerland – February 11-12, 2010

BIO 2010

Chicago, USA – May 3-6, 2010
Booth #4538

GLYCOTOPE moves to new premises

10 Dec 2009

GLYCOTOPE receives regulatory approval for GlycoExpress Technology and initiates first clinical trial with lead antibody GT-MAB 2.5 GEX

23 Nov 2009